Julie Smith's Net Worth
$1.64 Million
Who is Julie Smith?
Julie Smith has an estimated net worth of $1.64 Million. This is based on reported shares across multiple companies, which include EXELIXIS, INC., Stoke Therapeutics, Inc., Audentes Therapeutics, Inc., and Raptor Pharmaceutical Corp.
SEC CIK
Julie Smith's CIK is 0001557928
Past Insider Trading and Trends
2016 was Julie Smith's most active year for acquiring shares with 4 total transactions. Julie Smith's most active month to acquire stocks was the month of April. 2016 was Julie Smith's most active year for disposing of shares, totalling 5 transactions. Julie Smith's most active month to dispose stocks was the month of September. 2014 saw Julie Smith paying a total of $199,996.50 for 320,015 shares, this is the most they've acquired in one year. In 2016 Julie Smith cashed out on 677,583 shares for a total of $989,442.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
EXELIXIS, INC. (EXEL) Snapshot price: $25.13
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -30.28% | -4.68K |
—
|
—
| 10.78K |
Aug 13
| |||
Form 4
| +183.93% | 10.02K |
—
|
—
| 15.46K |
May 31
| |||
Form 4
| -83.36% | -27.28K |
$21.12 | -$576,153.60 | 5.45K |
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
| +100.75% | 16.42K |
—
|
—
| 32.73K |
May 27
| |||
Form 4
| +2,036.44% | 15.54K |
—
|
—
| 16.3K |
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
∞
| 763 |
—
|
—
| 763 |
Sep 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Stoke Therapeutics, Inc. (STOK) Snapshot price: $14.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Audentes Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Raptor Pharmaceutical Corp No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -109.94K |
$9.00 | -$989,442.00 |
0
|
Oct 24 - Oct 25
| |||
Form 4
| +169.11% | 64.18K |
—
|
—
| 102.13K |
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
∞
| 37.95K |
$5.27 | $199,996.50 | 37.95K |
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |